Insitro Receives $25M in Milestone Payments from Bristol Myers Squibb
18 Dec 2024 //
BUSINESSWIRE
Lilly, insitro Enter Strategic Agreements for Metabolic Diseases
10 Oct 2024 //
BUSINESSWIRE
Lilly, insitro Enter Strategic Agreements for Metabolic Diseases
09 Oct 2024 //
BUSINESSWIRE
insitro Hires AI/ML Visionary Emily Fox As SVP
30 Apr 2024 //
BUSINESSWIRE
Leading Clinical Research Innovator, Amy Joins insitro Board of Directors
03 Apr 2024 //
BUSINESSWIRE
Insitro Hires CMO to Advance Therapeutic Programs Toward the Clinic
08 Jan 2024 //
BUSINESSWIRE
Insitro to Present at the 42nd Annual J.P. Morgan Healthcare Conference
20 Dec 2023 //
BUSINESSWIRE
insitro Appoints Philip Tagari as CSO
01 Dec 2022 //
BUSINESSWIRE
insitro Appoints Philip Tagari as Chief Scientific Officer
01 Dec 2022 //
BUSINESSWIRE
insitro Announces Formation of Scientific Advisory Board
02 May 2022 //
BUSINESSWIRE
insitro and Genomics England Announce Partnership
09 Mar 2022 //
BUSINESSWIRE
insitro Appoints Tom Stocky as Vice President of Product
07 Sep 2021 //
BUSINESSWIRE
insitro Raises $400 Million in Series C Financing
15 Mar 2021 //
BUSINESSWIRE
Insitro CEO: Machine learning`s time is here, thanks to COVID-91
11 Jan 2021 //
FIERCEBIOTECH
BMS collaborates with insitro to develop drugs for ALS
29 Oct 2020 //
PHARMATIMES
insitro Announces Five-Year Discovery Collaboration with Bristol Myers Squibb
27 Oct 2020 //
BUSINESSWIRE
insitro Strengthens Machine Learning-Based Drug Discovery with Acquisition
22 Oct 2020 //
BIOSPACE
insitro Adds Biopharma Industry Leader Roger Perlmutter as First Independent
01 Oct 2020 //
BUSINESSWIRE
Insitro nets $143M to ramp up machine learning drug discovery
27 May 2020 //
FIERCE BIOTECH
insitro Announces $143 Million Raised in Series B Financing
26 May 2020 //
BUSINESSWIRE
Insitro signs on Stanford, Illumina alum as new chief data officer
05 Dec 2019 //
FIERCE BIOTECH
Star founders, investigators huddle around new Boston accelerator spotlighting
13 Sep 2019 //
ENDPTS
Gilead and insitro Ink Drug Discovery Deal
23 Apr 2019 //
PRESS RELEASE
Gilead teams up with Insitro for experimental NASH treatments
17 Apr 2019 //
REUTERS
Gilead & insitro Announce Strategic Collaboration Nonalcoholic Steatohepatitis
16 Apr 2019 //
BUSINESSWIRE